Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

Author： Sabuncu T.   Harma M.   Harma M.   Nazligul Y.   Kilic F.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.80, Iss.5, 2003-11, pp. : 1199-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

By Fruzzetti F.   Bersi C.   Parrini D.   Ricci C.   Genazzani A.R.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 936-944

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome and metabolic syndrome

By Hayden Catherine J   Balen Adam H  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 2, 2006-11 ,pp. : 183-194

Informa Healthcare

Access to resources Recommend Favorite

The metabolic aspects of polycystic ovary syndrome

By Yasmin Ephia   Balen Adam H  

Expert Review of Obstretrics and Gynecology, Vol. 6, Iss. 3, 2011-05 ,pp. : 331-341

Informa Healthcare

Access to resources Recommend Favorite

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

By Yildirim B.   Sabir N.   Kaleli B.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1358-1364

Elsevier

Access to resources Recommend Favorite

Glucose intolerance in Japanese patients with polycystic ovary syndrome

By Kurioka Hiroko   Takahashi Kentaro   Miyazaki Kohji  

Archives of Gynecology and Obstetrics, Vol. 275, Iss. 3, 2007-03 ,pp. : 169-173

Springer Publishing Company

Access to resources Recommend Favorite